Neuralstem Reports First Quarter 2017 Fiscal Results Provides Clinical and Business Update
10 mai 2017 16h05 HE
|
Neuralstem, Inc.
GERMANTOWN, Md., May 10, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing next generation treatments for nervous system diseases, reported its financial...
Neuralstem to Present at 29th Annual ROTH Conference
08 mars 2017 07h03 HE
|
Neuralstem, Inc.
GERMANTOWN, Md., March 08, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell...
Neuralstem Announces the Closing of $20 Million Strategic Investment from Tianjin Pharmaceutical Group International Holdings Co., LTD.
12 déc. 2016 07h38 HE
|
Neuralstem, Inc.
GERMANTOWN, Md., Dec. 12, 2016 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of central nervous system therapies based on its neural...
FXCM Implements New Index Trading Backend Technology
26 oct. 2015 02h00 HE
|
Global Brokerage, Inc.
LONDON, Oct. 26, 2015 (GLOBE NEWSWIRE) -- FXCM Inc. (NYSE:FXCM), a leading online provider of foreign exchange (FX) trading and related services, today announced that is has upgraded its...